Provectus Biopharmaceuticals Inc (PVCT)

[Mokyo Toe]

Yeah, I was hopin' we were gonna hold .04, but deflated again.

Here is what I am watching for February 2018:

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma (Phase 3)

https://clinicaltrials.gov/ct2/show/NCT02288897

This had been scheduled earlier but was delayed.

Pivotal melanoma Phase 3 trial of PV-10. Provectus' CTO Dr. Eric Wachter, PhD noted a 6-month delay:
"I must unfortunately report that we are behind with regard to our initial schedule for reaching the interim and final analysis triggers for the study. I’m confident that we are implementing the proper study to support licensure of PV-10, but our present estimate that we are approximately six months behind schedule with regard to site start-up, patient recruitment and eventual data read-out."
Prior guidance had been an estimated primary completion date (per ClinicalTrials.gov) of September 2017, and an interim assessment of safety and efficacy of June 2016 (halfway between an April 2015 study start date and the estimated completion date). Adding six months, purely on the basis of math, would push the interim and complete data read-outs to December 2016 and February 2018, respectively.

http://provectuspharmaceuticalsinc.blogspot.com/p/current-news_1.html

Also, we should be getting this too:

A Study to Assess PV-10 Chemoablation of Cancer of the Liver (Phase 1)

https://clinicaltrials.gov/ct2/show/NCT00986661

There may be more delays, but for the sake of the company I really hope not...